21Shares files for Injective ETF amid growing institutional interest

21Shares, a prominent issuer of crypto exchange-traded products, has filed for a new Exchange-Traded Fund (ETF) centered on Injective, a blockchain protocol designed to serve as infrastructure for global finance, featuring high-performance consensus and native financial primitives. This filing underscores the increasing trend of traditional finance integrating digital assets into mainstream portfolios, simplifying access through regulated investment vehicles. The move is part of 21Shares' ongoing expansion of crypto offerings, which recently included UK retail listings and products tied to decentralized computing, AI, and scalable Web3 architectures.

(Source：Crypto Briefing)